As more particularly described in clause 3 of the debenture, a debenture creating fixed and floating charges over all the assets and undertakings (present and future) of quantum pharma 2014 limited including without limitation 318,374 B2 ordinary shares, 2,100,701 deferred shares, 101,000 preference shares, 100 2012 preference share and 1 2014 preference share held by quantum pharma 2014 in hamsard 3149 limited including distribution rights.

As more particularly described in clause 3 of the debenture, a debenture creating fixed and floating charges over all the assets and undertakings (present and future) of quantum pharma 2014 limited including without limitation (1) 318,374 B2 ordinary shares, (2) 2,100,701 deferred shares, (3) 101,000 preference shares, (4) 100 2012 preference shares and (5) 1 2014 preference share held by quantum pharma 2014 limited in quantum pharma group limited including distribution rights.

As more particularly described in clause 3 of the debenture, a debenture creating fixed and floating charges over all the assets and undertakings (present and future) of quantum pharma 2014 limited including without limitation (1) 318,374 B2 ordinary shares, (2) 2,100,701 deferred shares, (3) 101,000 preference shares, (4) 100 2012 preference shares and (5) 1 2014 preference share held by quantum pharma 2014 limited in quantum pharma group limited including distribution rights.

UK registered trademarks, with registered numbers UK00003048218, UK00003048677, UK00003048684 and UK00003048689.